US Regulatory Reads, January: Top 10 Includes Trump, But Also FDA Fundamentals
Executive Summary
Actions coming out of the Trump administration are important to Medtech Insight readers, but so are detailed coverage of FDA policies not yet specifically impacted by the political change, as our top-10 US regulatory and policy stories in January shows.